Related Experiment Video
Updated: Apr 4, 2026
Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
Published on: May 10, 2022
Trends in Anemia and Iron Deficiency Among Nonpregnant U.S. Women of Reproductive Age, 1999-2023
Maggie Z X Xiao1, Jason Bentley, Andrew D Leavitt
1Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, Ontario, Canada; the Leeder Centre for Health Policy, Economics and Data, and Child Population and Translational Health Research, Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia; and the Department of Laboratory Medicine and the Department of Anesthesia and Perioperative Care, University of California, San Francisco, San Francisco, California.
Objective:
To evaluate temporal trends in the prevalence of anemia, iron deficiency, and iron deficiency anemia (IDA) among nonpregnant reproductive-aged women in the United States.
Methods:
In this serial cross-sectional study of NHANES (National Health and Nutrition Examination Surveys) from 1999-2000 through 2021-2023, nonpregnant women aged 20-45 years were included. Hemoglobin and ferritin data were used to evaluate time trends in anemia (defined as a hemoglobin concentration less than 12.0 g/dL), iron deficiency (defined as a serum ferritin level less than 15.0 micrograms/L), and IDA (defined as a hemoglobin concentration less than 12 g/dL and a serum ferritin level less than 15.0 micrograms/L).
Results:
A total of 8,200 U.S. nonpregnant reproductive-aged women were included in this analysis. The prevalence of anemia, iron deficiency, and IDA (weighted to the U.S. population) for the combined time periods was 9.8% (95% CI, 9.0-10.7%, 3.28 million), 17.3% (95% CI, 16.4-18.3%, 5.70 million), and 6.2% (95% CI, 5.5-6.8%, 2.03 million), respectively. The prevalence of anemia increased from 8.0% (95% CI, 5.8-10.9%) in 1999-2000 to 14.2% (95% CI, 11.8-17.1%) in 2021-2023. In contrast, there was a modest increase in the iron deficiency prevalence from 17.9% (95% CI, 16.4-19.5%) to 18.8% (95% CI, 16.1-21.9%). The IDA prevalence increased from 4.3% (95% CI, 3.2-6.0%) to 9.1% (95% CI, 7.3-11.4%). In adjusted logistic regression models with each NHANES survey cycle as a continuous variable, the odds of anemia and IDA each rose by approximately 8% per cycle (anemia: adjusted odds ratio [aOR] 1.08, 95% CI, 1.05-1.11; IDA: aOR 1.08, 95% CI, 1.04-1.12) between 1999 and 2023.
Conclusion:
In a population-based cohort of U.S. nonpregnant reproductive-aged women, the prevalence of anemia and IDA increased substantially between 1999-2000 and 2021-2023. The prevalence of iron deficiency remained high and showed no significant change over this period. Given that iron deficiency and anemia are important causes of disability, these findings may inform future screening policies for these conditions in nonpregnant reproductive-aged women.
Related Concept Videos
01:24Factors Affecting Erythropoiesis
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
01:27Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
01:28Menopause
01:30Current Trends in Nursing II
01:28Current Trends in Nursing I
01:29Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...